University of British Columbia, Department of Medicine (Division of Cardiology), Vancouver, B.C, Canada.
University of British Columbia, Department of Medicine (Division of Cardiology), Vancouver, B.C, Canada.
Int J Cardiol. 2021 May 15;331:138-143. doi: 10.1016/j.ijcard.2021.01.052. Epub 2021 Jan 30.
Heart failure with preserved ejection (HFpEF) represents nearly half of all patients with heart failure (HF). The objective of this study was to determine whether patient characteristics identify discrete kinds of HFpEF.
Data were collected on 196 patients with HFpEF in a non-hospitalized setting. Clinical and laboratory variables were collected, and 47 candidate variables were examined by the unsupervised clustering strategy partitioning around medoids. The Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) risk score was calculated. Follow-up data on all-cause mortality, cardiovascular mortality, and HF exacerbation, were collected and were not part of the data used to identify subgroups.
Six significantly different groups or clusters were found. There were three groups of women (i) individuals with a low proportion of vascular risk factors (HFpEF) (ii) individuals with a high proportion of hypertension and diabetes, but lower proportion of kidney disease and diastolic dysfunction (HFpEF (iii) older individuals with high rates of atrial fibrillation (AF), chronic kidney disease. They had the worst long-term outcomes (HFpEF). There were three groups of men (i) individuals with a high proportion of coronary artery disease (CAD), dyslipidemia, higher serum creatinine, and diastolic dysfunction (HFpEF)(ii) individuals with highest BMI, and high proportion of CAD, obstructive sleep apnea, and poorly controlled diabetes (HFpEF) (iii) individuals with high rates of AF, elevated BNP, biventricular remodeling (HFpEF). They had a high cardiovascular mortality.
HFpEF consists of a heterogenous group of individuals with six distinct clinical subsets that have different long-term outcomes.
射血分数保留的心衰(HFpEF)占心力衰竭(HF)患者的近一半。本研究旨在确定患者特征是否能识别不同类型的 HFpEF。
在非住院环境中收集了 196 例 HFpEF 患者的数据。收集了临床和实验室变量,并通过中位数周围分区的无监督聚类策略检查了 47 个候选变量。计算了 Meta-analysis Global Group in Chronic Heart Failure(MAGGIC)风险评分。收集了全因死亡率、心血管死亡率和 HF 恶化的随访数据,但这些数据不包括用于识别亚组的数据。
发现了六个显著不同的组或聚类。有三组女性:(i)血管危险因素比例低的个体(HFpEF);(ii)高血压和糖尿病比例高,但肾脏疾病和舒张功能障碍比例低的个体(HFpEF);(iii)年龄较大、房颤(AF)、慢性肾脏病发生率高的个体。她们的长期预后最差(HFpEF)。有三组男性:(i)冠状动脉疾病(CAD)、血脂异常、血清肌酐升高和舒张功能障碍比例高的个体(HFpEF);(ii)BMI 最高、CAD、阻塞性睡眠呼吸暂停和糖尿病控制不佳比例高的个体(HFpEF);(iii)AF、BNP 升高、双心室重构发生率高的个体(HFpEF)。他们有较高的心血管死亡率。
HFpEF 由一组具有不同长期预后的六个不同临床亚组的异质性个体组成。